Key result
Buccal smear protein shifts precede clinical disease onset in 70% of pediatric ACM gene carriers.
Why the study?
Arrhythmogenic cardiomyopathies cause significant sudden cardiac death in children, but diagnosis and risk stratification are hindered by incomplete penetrance and heterogeneous phenotypes. The timing of buccal mucosal protein redistribution and its correlation with disease progression remained unknown.
Does buccal epithelium protein redistribution precede clinical disease onset in pediatric arrhythmogenic cardiomyopathy gene carriers?
Cohort (n=99)
Does buccal epithelium protein redistribution precede clinical disease onset in pediatric arrhythmogenic cardiomyopathy gene carriers?
Buccal epithelium protein shifts precede clinical disease onset in pediatric arrhythmogenic cardiomyopathy gene carriers, offering a potential non-invasive tool for early risk stratification.
Answers are grounded in this paper and cite their sources.
May flag pre-symptomatic pediatric ACM carriers; challenges prior assumptions of no pre-clinical changes but leaves open validation before adoption.
Background information Arrhythmogenic cardiomyopathies (ACM) account for >10% of sudden cardiac deaths (SCD) in the paediatric population. There is need to drastically improve diagnosis and risk stratification, largely hindered by heterogeneous phenotypic manifestations and incomplete penetrance. Many ACM phenotypes are caused by variants in genes encoding desmosomal proteins, most commonly desmoplakin (DSP) and plakophilin 2 (PKP2), alongside plakoglobin (JUP), desmoglein 2 (DSG2), and desmocollin 2 (DSC2). Immunohistochemical studies have shown the buccal mucosa to mirror changes in junctional and signalling protein distribution observed in the myocardial tissue of ACM patients. Our previous pilot work showed that children bearing ACM variants show no such abnormalities unless and until clinical onset of disease. Purpose/Aim We aimed to establish the timepoint at which key protein redistribution occurs in a large cohort of paediatric ACM gene carriers, and how further protein shifts correlate with disease progression. In addition, we analysed key protein localisation in a number of gene-elusive children showing minor cardiac abnormalities. Methods Paediatric silent desmosomal (n=44) or Titin (TTN) (n=7) variant carriers, patients with a definite/probable ACM diagnosis (n=27), and individuals showing clinical abnormalities from gene elusive families (n=21) were recruited and buccal smears collected every 3-6 months over a time period of 7 years. Buccal smears were subjected to immunocytochemistry to investigate the distribution of desmosomal proteins DSP, PKP1 and JUP, and the major gap junction protein connexin43 (Cx43). Results All children with an established/likely diagnosis of ACM showed protein distribution changes. Further protein shifts were observed to correlate with disease progression/worsening symptoms. 27 paediatric ACM gene carriers (70%) exhibited protein shifts on initial or subsequent samples prior to clinical onset of disease. Of 10 gene carriers that developed disease during the study, 8 (80%) showed 1 or more protein shifts before disease manifestation. All TTN carriers displayed abnormal protein distribution prior to disease onset. 12 children from gene-elusive families (57%) showed abnormal protein distribution before disease onset, with 5 patients (80%) who progressed to ACM diagnosis showing protein abnormalities before fulfilment of diagnostic criteria. For these patients, buccal cell changes accompanied clinical changes. Only 2 patients (2%) in the cohort showed disease onset in the absence of protein abnormalities. Conclusion This longitudinal study shows that protein shifts not only correlate with ACM manifestation but instead precede disease onset. This method may allow for identification of at-risk individuals in advance of signs exhibited by clinical modalities, with important implications for early risk stratification.
No takes yet. Share an insight, caveat, or question.
Jager et al. (2025) conducted a cohort in Arrhythmogenic cardiomyopathies (n=99). Buccal epithelium protein distribution changes was evaluated on Abnormal buccal epithelium protein distribution prior to disease onset. Buccal epithelium protein shifts preceded clinical disease onset in 80% of paediatric ACM gene carriers who developed the disease during a 7-year longitudinal study.
Synapse has enriched 10 related papers. Consider them for comparative context: